All episodes
Episode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers
Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest
Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data
Episode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season
Episode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'
Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts
Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China
Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype
Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT
Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO
Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?
Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen
Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes
Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?
Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics
Episode #8 - Megamergers, migraines, and biotech's Four Horsemen
Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism
Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR
Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr
Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card
Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?
Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies
Episode #1 - Shkreli's sentence, biotech froth, and a blood party
Coming soon: "The Readout LOUD"